FDA Tackles Beta-Lactam Antibiotics in Cross-Contamination Guidance
The FDA issued new guidance in March 2011 to help manufacturers decide when separate buildings are necessary to prevent non-penicillin beta-lactam antibiotics from cross contaminating other pharmaceuticals.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.